Peer-reviewedCC BYCancers
Distinct Molecular Landscape and Clinical Subtype of HPV-Positive Esophageal Squamous Cell Carcinoma
- 1Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China
- 2Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China
Related
- Institutional enrollment volume and clinical outcomes after surgery or chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma: a supplementary analysis of JCOG0502
- Gene prioritization across ancestries uncovers distinct molecular pathophysiology and therapeutic landscape in polycystic ovary syndrome
- Clinical and CT body-composition model for major pathological response to neoadjuvant tislelizumab, albumin-bound paclitaxel, and nedaplatin in esophageal squamous cell carcinoma
- Integrated Transcriptomic and Regulatory Network Analysis Reveals Distinct Molecular Subtypes with Prognostic Significance in Clear Cell Renal Cell Carcinoma
- High concordance in molecular profiles between primary tumors and matched lymph node metastases in differentiated thyroid carcinoma: implications for clinical sample selection
BibTeX
@article{li2026distinct,
title = {{Distinct Molecular Landscape and Clinical Subtype of HPV-Positive Esophageal Squamous Cell Carcinoma}},
author = {Hang Li and Xuxia Shen and Yan Jin and Hong Hu and Jiaqing Xiang and Yawei Zhang},
journal = {Cancers},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664334},
note = {CC BY},
}
RIS
TY - JOUR
TI - Distinct Molecular Landscape and Clinical Subtype of HPV-Positive Esophageal Squamous Cell Carcinoma
AU - Hang Li
AU - Xuxia Shen
AU - Yan Jin
AU - Hong Hu
AU - Jiaqing Xiang
AU - Yawei Zhang
PY - 2026
DA - 2026/09/24
JO - Cancers
UR - https://europepmc.org/article/PMC/PMC13664334
SN - 2072-6694
ER -